French Guiana Tech World
SEE OTHER BRANDS

Your science and technology news reporter from French Guiana

French Guiana Tech World: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Tech World.

Press releases published on April 12, 2025

Texas Hold'em Revolution: MLPoker Emerges as Premier Online Poker Destination in 2025

Texas Hold'em Revolution: MLPoker Emerges as Premier Online Poker Destination in 2025

MLPoker Image LOS ANGELES, April 12, 2025 (GLOBE NEWSWIRE) -- As the global poker community celebrates record-breaking participation in the 2025 World Series of Poker (WSOP), a new digital powerhouse is transforming online card gaming. MLPoker has rapidly …

ExoraPad Launches On Magnetic DEX, Set To Go Live on Mainnet By Q3 2025

ExoraPad Launches On Magnetic DEX, Set To Go Live on Mainnet By Q3 2025

CORK, Ireland, April 12, 2025 (GLOBE NEWSWIRE) -- Investors who missed out on ExoraPad’s presale now have an ideal chance to join early, as $EXP token officially started trading on Magnetic DEX. The EXP/XRP trading pair is already seeing significant …

Breach and Attack Simulation Market CAGR to be at 22.1% By 2032 | Simulating Cyber Threats to Strengthen Security

Breach and Attack Simulation Market CAGR to be at 22.1% By 2032 | Simulating Cyber Threats to Strengthen Security

Tools and services designed to simulate cyberattacks to identify vulnerabilities and enhance cybersecurity defense systems. LOS ANGELES, CA, UNITED STATES, April 11, 2025 /⁨EINPresswire.com⁩/ -- According to a new report published by Market Research …

Vantage Biosciences 的口服藥 VX-01 用於治療非增生性糖尿病視網膜病變,在其第 2 期臨床研究中,首次安排患者完成服藥

Vantage Biosciences 的口服藥 VX-01 用於治療非增生性糖尿病視網膜病變,在其第 2 期臨床研究中,首次安排患者完成服藥

倫敦, April 12, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences 是一間臨床階段生物科技公司,致力開發治療糖尿病眼疾的創新療法。該公司今天宣布,在其評估 VX-01 的第 2 期臨床研究中,首次安排患者成功服藥。VX-01 是一種用於治療非增生性糖尿病視網膜病變 (NPDR) 的口服藥。 糖尿病視網膜病變影響全球逾 1 億人,是就業年齡成人失明的主要原因之一。 如果不及時介入,NPDR 可能會導致糖尿病眼疾的情況變得更加嚴重,增加視力受損的風險。 …

Volektra Raises Capital to Commercialize Virtual Magnet Motor for Mobility, Industry, and Defense

Volektra Raises Capital to Commercialize Virtual Magnet Motor for Mobility, Industry, and Defense

SACRAMENTO, Calif., April 12, 2025 (GLOBE NEWSWIRE) -- Electric drivetrain innovator Volektra has secured a new funding round to commercialize its proprietary Virtual Magnet motor technology—an industry-first breakthrough that eliminates rare earth magnets …

Kane Biotech Announces New Agreement with Outside the Box Capital Inc.

Kane Biotech Announces New Agreement with Outside the Box Capital Inc.

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba,, April 11, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (“Kane Biotech” or the “Company”) announces today that it has terminated …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service